Starna Therapeutics公司简介:官方网站近期动态11-18辉瑞付星锐医药 3.3 亿美元首付款,取得体内 CAR-T 疗法独家许可星锐医药开发体内 CAR-T 项目并出让许可,收取首付款,可获里程碑款和销售提成。1,2看这张卡 ›这件事怎么走Pfizer买许可的药企支付许可首付款3.3 亿美元首付款2Starna Therapeutics出让许可的 RNA 药企R1“Pfizer will pay Starna US$330 million upfront and could pay up to US$2.3 billion more if the treatments meet development, regulatory and sales milestones.”2资料来源辉瑞与星锐医药就自身免疫疾病签订独家许可协议,2026-11-18英文虎报:辉瑞以最高 26 亿美元的交易从中国星锐医药获得 CAR-T 疗法许可,2026-11-18Pfizer · FinancialContent - Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases,2026-11-18